Literature DB >> 27156667

PET, PET/CT, and PET/MR Imaging Assessment of Breast Cancer.

Shamim Ahmed Shamim1, Drew A Torigian2, Rakesh Kumar3.   

Abstract

This review focuses mainly on clinical applications of PET/CT in patients with breast cancer. It discusses the role of 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) PET/CT (and FDG PET) in the diagnosis and initial staging of breast cancer, in monitoring the response of disease to chemotherapy, and in identifying metastatic and recurrent disease. In addition, it discusses the role of MR imaging and potential future hybrid modalities such as PET/MR imaging.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Computed tomography (CT); Magnetic resonance imaging (MRI); Oncology; PET mammography; PET/CT; PET/MRI; Positron emission tomography (PET)

Year:  2009        PMID： 27156667     DOI： 10.1016/j.cpet.2009.01.001

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  1 in total

Review 1.  Current Status of Hybrid PET/MRI in Oncologic Imaging.

Authors:  Andrew B Rosenkrantz; Kent Friedman; Hersh Chandarana; Amy Melsaether; Linda Moy; Yu-Shin Ding; Komal Jhaveri; Luis Beltran; Rajan Jain
Journal:  AJR Am J Roentgenol       Date:  2015-10-22       Impact factor: 3.959
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.